| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
About This CME Activity
|
|
|
2010
|
7 |
4 |
p. 166-
1 p.
|
artikel
|
| 2 |
All that glitters is not gold: cancer-mimicking lesion in a cancer survivor
|
Kassem, Mohammed A.
|
|
2010
|
7 |
4 |
p. 175-177
3 p.
|
artikel
|
| 3 |
A new treatment option for refractory CLL arrives
|
Mehta, Dhaval
|
|
2010
|
7 |
4 |
p. 153-
1 p.
|
artikel
|
| 4 |
At last, healthcare reform: it's time to make it work
|
Bosserman, Linda D.
|
|
2010
|
7 |
4 |
p. 147-
1 p.
|
artikel
|
| 5 |
Decreasing the frequency of medical oncology admissions: progress toward a laudable goal
|
Mintzer, David M.
|
|
2010
|
7 |
4 |
p. 155-159
5 p.
|
artikel
|
| 6 |
Evolving understanding and current management of patients with cancer of unknown primary site
|
Greco, F. Anthony
|
|
2010
|
7 |
4 |
p. 183-188
6 p.
|
artikel
|
| 7 |
Firstline treatment of patients with chronicphase chronic myelogenous leukemia: progress and remaining questions
|
Devetten, Marcel P.
|
|
2010
|
7 |
4 |
p. 160-165
6 p.
|
artikel
|
| 8 |
Healthcare reform: a mixed bag for oncology
|
Young, Patrick
|
|
2010
|
7 |
4 |
p. 192-
1 p.
|
artikel
|
| 9 |
ITP in Patients With CLL: Practicing With Patrick F. Fogarty, MD
|
|
|
2010
|
7 |
4 |
p. 166-167
2 p.
|
artikel
|
| 10 |
Ofatumumab for fludarabine- and alemtuzumab-refractory CLL
|
Abraham, Jame
|
|
2010
|
7 |
4 |
p. 151-152
2 p.
|
artikel
|
| 11 |
Oncology apps for your smart phone
|
Fried, John J.
|
|
2010
|
7 |
4 |
p. 182-
1 p.
|
artikel
|
| 12 |
Paraneoplastic polymyositis associated with mesothelioma: a brief report
|
Schuster, Steven R.
|
|
2010
|
7 |
4 |
p. 178-180
3 p.
|
artikel
|
| 13 |
Two for t: two groups and t-tests
|
Norman, Geoffrey R.
|
|
2010
|
7 |
4 |
p. 189-191
3 p.
|
artikel
|
Tijdschrift beschrijving